Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
December 08 2020 - 7:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2020
Commission File Number: 001-39034
(Name of registrant)
275 Armand-Frappier Blvd.
Laval, Québec
H7V 4A7
Canada
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
BELLUS Health Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date: December 8, 2020
|
By:
|
/s/ Ramzi Benamar
|
|
|
|
|
Name: Ramzi Benamar
|
|
|
|
|
Title: Chief Financial Officer
|
|
|
|
|
|
|
Form 6-K Exhibit Index
|
Exhibit Number
|
|
Document Description
|
|
|
|
|
|
|
|
|
|
|
|
|
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Mar 2024 to Apr 2024
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Apr 2023 to Apr 2024
